Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis

Annals of the Rheumatic Diseases

Volumn 56, Issue 1, 1997, Pages 37-40

  Tuokko, Juha ^a,b   Reijonen, Helena ^c   Ilonen, Jorma ^c   Anttila, Kaisa ^c   Nikkari, Simo ^a,b   Möttönen, Timo ^d,e   Yli Kerttula, Urpo ^e,f   Toivanen, Auli ^d,e  

^a TURKU UNIVERSITY   (Finland)

^b Depts Med Microbiol and Dermatol   (Finland)

^c Department of Virology ^*

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e Department of Medicine

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS;

EID: 0031019337     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.1.37     Document Type: Article

References (36)

1. Kingsley G, Sieper J. Current perspectives in reactive arthritis. Immunol Today 1993;14:387-90.
2. Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993;342:646-50.
3. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria:implications for spondylarthropaties. Lancet 1995;345:1542-4.
4. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993;150:4168-78.
5. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 1995;182:1153-8.
6. de Castro JAL. Structural polymorphism and function of HLA-B27. Curr Opin Rheumatol 1995;7:270-8.
7. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993;178:27-47.
8. Lanchbury JS. The HLA association with rheumatoid arthritis. Clin Exp Rheumatol 1992;10:301-4.
9. Toivanen A. Reactive arthritis. In: Klippel JH, Dieppe PA. Rheumatology. London: CV Mosby, 1993.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
12. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours:An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
13. Victoria-Gutierrez M, Martinez-Naves E, Coto E, Dominquez O, Uria F, Urra JM, et al. DNA analysis of HLA-DR4B1 subtypes on multiple sclerosis by specific oligonucleotide probes. J Neuroimmunol 1991;32:279-83.
14. Bodmer JG, Marsh SGE, Albert ED, Bodmer EF, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system. Tissue Antigens 1994;44:1-18.
15. Reijonen H, Ilonen J, Åkerblom HK, Knip M, Dosch HM, Childhood Diabetes in Finland (DiMe) Study Group. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. Tissue Antigens 1994; 43:1-6.
16. Dominquez O, Coto E, Martinez-Naves E, Choo SY, Lopez-Larrea C. Molecular typing of HLA-B27 alleles. Immunogenetics 1992;36:277-82.
17. Olerup O. HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens 1994;43:253-6.
18. Monowarul-Islam SM, Numaga J, Fujino Y, Masuda K, Ohda H, Hirata R, et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum 1995; 4:547-50.
19. Ploski R, Flato B, Vinje O, Maksymowych W, Førre Ø, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Human Immunol 1995;44:88-96.
20. Inman RD, Johnston MEA, Hodge M, Falk J, Helewa A. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 1988;31:1377-83.
21. Mielants H, Veys EM, Joos R, Noens L, Cuvelier C, De Vos M. HLA antigens in seronegative spondylarthropaties. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. J Rheumatol 1987;14:466-71.
22. Repo H, Leirisalo-Repo M, Gribenberg M, Koskimies S, Kontiainen S, Laitinen O. Yersinia arthritis, immune functions and histocombatibility antigens. APMIS 1986; 94:242-52.
23. Ilonen J, Reijonen H. Special genetic features of the populations in Nordic countries as related to risk of IDDM. Diabetes in the Young 1993;29:10-16.
24. Ilonen J, Reijonen H, Arvilommi H, Jokinen L, Möttönen T, Hannonen P. HLA-DR antigens and HLA-DQβ chain polymorphism in susceptibility to rheumatoid arthritis. Ann Rheum Dis 1990;49:494-6.
25. Ilonen J, Hakala M, Reijonen H, Tiilikainen A. B27-bearing HLA haplotypes in rheumatoid arthritis: characterization in Finnish patients. Hum Immunol 1991;30:7-10.
26. Singal DP, Green D, Reid B, Gladman DD, Buchanan WW. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis 1992;51:23-8.
27. Singal DP, D'Souza M, Reid B, Bensen WG, Kassam YB, Adachi JD. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet 1987;ii:1118-20.
28. Sansom DM, Bidwell JL, Maddison PJ, Gampion G, Klouda PT, Bradley BA. HLA DQa and DQb restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol 1987;19:269-78.
29. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995;16:274-8.
30. Laivoranta S, Ilonen J, Tuokko J, Luukkainen R, Toivanen A. HLA-frequencies of HLA-B27 negative patients with reactive arthritis. Clin Exp Rheumatol 1995;13:637-40.
31. Westman P, Partanen J, Leirisalo-Repo M, Koskimies S. Different DRB1*04 alleles predominate in the Finnish random population and in HLA-B27-positive subpopulations. Tissue Antigens 1994;44:329-31.
32. Westman P, Partanen J, Leirisalorepo M, Koskimies S. HSP70-Hom NcoI polymorphism and HLA-associations in the Finnish population and in patients with ankylosing spondylitis or reactive arthritis. Eur J Immunogenet 1994; 21:81-90.
33. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995;7:263-9.
34. Maksymowych WP, Tao S, Li Y, Wing M, Russell AS. Allelic variation at the TAP 1 locus influencies disease phenotype in HLA-B27 positive individuals with ankylosing spondylitis. Tissue Antigens 1995;45:328-32.
35. Barron KS, Reveille JD, Carrington M, Mann DL, Robinson MA. Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. Arthritis Rheum 1995;38:684-9.
36. Obst R, Armandola EA, Nijenhuis M, Momburg F, Hämmerling GJ. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol 1995;25:2170-6.